Lumicell Direct Visualization System (DVS)
FDA premarket approval P230014/S003 · decided 2025-01-03
Approval details
- PMA number
- P230014
- Supplement
- S003
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- Lumicell Direct Visualization System (DVS)
- Generic name
- Fluorescence imaging for breast cancer detection
- Applicant
- Lumicell, Inc.
- Date received
- 2024-11-14
- Decision date
- 2025-01-03
- Days to decision
- 50 days
- Decision code
- APPR
- Product code
- SAW
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Newton, MA
- Statement
- Approval for a labeling update to add vaporized hydrogen peroxide cycles to the validated sterilization methods for reprocessing the Handheld Probe and Sterilization Tray used as part of the Lumicell DVS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.